Latest Articles

Publication Date
All News Scientific
Mary Lou McDonald calls for dedicated Endometriosis treatment centre and provision of excision surgery - vote.sinnfein.ie

Mary Lou McDonald calls for dedicated Endometriosis treatment centre and provision of excision surgery vote.sinnfein.ie

Published: April 23, 2025, 7:31 p.m.
Read Full Article
The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval - Labiotech.eu

The emergence of BTK inhibitors in multiple sclerosis treatment: Companies close in on approval Labiotech.eu

Published: April 23, 2025, 1:01 p.m.
Read Full Article
These biotech startups could change how we treat hepatitis B - Labiotech.eu

These biotech startups could change how we treat hepatitis B Labiotech.eu

Published: April 22, 2025, 8:19 a.m.
Read Full Article
This Wellness Retreat Changed My Relationship With My Body - essence.com

This Wellness Retreat Changed My Relationship With My Body essence.com

Published: April 21, 2025, 3:37 p.m.
Read Full Article
Chronic Pelvic Pain Treatment Market Size will Projected to Hit - openPR.com

Chronic Pelvic Pain Treatment Market Size will Projected to Hit openPR.com

Published: April 18, 2025, 12:17 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - BioSpace

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 5:25 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - The Malaysian Reserve

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 18, 2025, 12:16 a.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Yahoo Finance

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to show an overall survival benefit - Newswire.ca

Health Canada expands Jemperli (dostarlimab for injection) plus chemotherapy approval to all adult patients with primary advanced or first recurrent endometrial cancer, as the first and only immuno-oncology-based treatment to …

Published: April 17, 2025, 5:15 p.m.
Read Full Article
Popular spa treatment leaves one dead - Herald Sun

Popular spa treatment leaves one dead Herald Sun

Published: April 16, 2025, 8:44 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!